10
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Modified Iridoid Glycosides (Part-1): Syntheses of 4′-5′-unsaturated Iridoid Glycosides from Loganin and Arbortristoside-A

, &
Pages 51-58 | Received 25 May 1995, Published online: 04 Oct 2006

References

  • Jolad , S. , Hoffman , J. J. , Wiedhopf , R. M. , Cole , J. R. , Bates , R. B. and Kriek , G. R. 1976 . Antitumor Agent From Penstemon Deutus Douge. Ex. Lindl (Scrophulariaceae): penstemide: A novel irridoid type glucoside . Tetrahedron Letters , 46 : 4119 – 4120 .
  • Jensen , S. R. , Nielsen , B. J. , Mikkelson , C. B. , Hoffman , J. J. , Jolad , S. D. and Cole , J. R. 1979 . Revised structure of penstemide . Tetrahedron letters , 35 : 3261 – 3262 .
  • Muzaffar Alam , T. S. and Purushothaman , K. K. 1986 . inhibitory activity of Arbortristoside-A on Fibrosarcoma in albino rats . Arogya: Journal of Health Science , XII : 122 – 130 .
  • Dwivedi , Y. , Rastogi , R. , Chander , R. , Sharma , S. K. , Kapoor , N. K. , Garg , N. K. and Dhawan , B. N. 1990 . Hepatoprotective activity of picroliv against carbon tetrachloride induced liver damage in rats . Indian Journal of Medical Research , 92 : 195 – 200 .
  • Tandon , J. S. , Srivastava , V. and Guru , P. Y. 1991 . Irridoids: A new class of Leishmanicidal Agents from Nyctanthus-Arbortristis . Journal of Natural Products , 54 : 1102 – 1104 .
  • Chitravanshi , V. C. , Singh , A. P. , Goshal , S. , Krishna Prasad , B. N. , Srivastava , V. and Tandon , J. S. 1992 . Therapeutic action of Nyctanthus Arbortristis against Caecal Ameobiasis of Rat . International Journal of Pharmacognosy , 30 : 71 – 75 .
  • EL Naggar , L. J. and Beal , J. L. 1980 . Iridoids A Review . Journal of Natural Products. , 43 : 649 – 707 .
  • Boros , A. C. and Stermitz , R. F. 1991 . Iridoids: An updated Review Part I . Journal of Natural Products , 53 : 1055 – 1147 .
  • Boros , A. C. and Beal , J. L. 1991 . Iridoids: An updated Review Part II . Journal of Natural Products , 54 : 1173 – 1246 .
  • Battersby , A. R. , Hall , E. S. and Southgate , R. 1969 . Journal of Chemical Society(C) , : 721
  • Whistler , R. L. and BeMiller , J. N. 1972 . Methods in carbohydrate chemistry , Vol. 6 , 411 New York : Academic Press . Such reactions are reported previously in sugar chemistry for protection and deprotection
  • Tanashashi , T. , Nagakura , N. , Inouye , H. and Zenk , H. M. 1984 . Radioimmuno assay for Determination of Logain and the Biotransformation of Logain to Secologarin by Plant Cell Cultures . Phytochemistry , 23 : 1917 – 1922 .
  • Cree , G. M. , Mackie , D. W. and Perlin , A. S. 1969 . Canadian Journal of Chemistry , 47 : 511
  • Harton , D. and Liav , A. 1972 . Carbohydrate Research , 24 : 105
  • Spectral data of some selected compounds are given below: 7 MS (FAB) m/z 453 (M++1), 473 (M+Na); [α]D=-116.66 (C=0.10 in CHCl3); 1-H NMR (400 MHz, CDCl3), δ 9.30 (s, 1H, CHO), 7.43 (s, 1H, H-3), 6.06 (d, 3.4, 1H, H-4′), 5.63 (d, 4.4, 1H, H-1′), 5.48 (d, 3.9, 1H, H-1), 5.34 (t, 6.8, 1H, H-3′), 5.13 (t, 6.8, 1H, H-2′), 3.74 (s, 3H, OCH3), 3.18 (m, 1H, H-5), 2.58 (m, 2H, H-6), 2.22 (m, 1H, H-9), 2.75 (m, 1H, H-8), 2.10 (s, 6H, 2 × COCH 3), 1.15 (d, 7, 3H, H-10), 13C NMR (100 MHz, CDCl3), δ218.18 (C-7), 185.61 (CHO), 169.63 (OCOCH3),168.89, 166.30 (OCOCH3 × 2), 150.70 (C-3), 149.26 (C-5′), 115.74 (C-4′), 110.74 (C-4), 93.77 (C-1), 92.94 (C-1′), 68.16 (C-2′), 64.45 (C-3′), 51.29 (OCH3), 45.21 (C-9), 42.96 (C-8), 41.85 (C-6), 26.55 (C-5), 20.74, 20.37 (COCH3 × 2), 13.25 (C-10). 8b. MS (FAZm/z 457 (M++1), 479 (M++Na); [α]D=-106.68 (C=0.-11 in CHCl3), 1H NMR (400 MHz, CDCl3), δ7.45 (s, 1H, H-3), 5.58 (d, 2, 1H, H-1′), 5.28 (d, 5, 1H, H-1), 5.20 (d, 5, 1H, H-4′), 5.13 (bs, 1H, H-2′), 5.08 (bs, 1H, H-3′), 4.10 (q, 30, 12, 2H, H-6′), 3.88 (m, 1H, H-7), 3.71 (s, 3H, OCH3), 2.90 (m, 1H, H-5), 2.63 (m, 1H, H-6), 2.11 (s, 3H, OCOCH 3), 2.07 (s, 3H, OCOCH 3), 1.93 (m, 1H, H-8), 1.72 (m, 1H, H-9), 1.39 (m, 1H, H-6ß), 1.11 (d, 9, 3H, H-10), 13C NMR (100 MHz, CDCl3), δ 179.11 (COOCH3), 169.29 (OCOCH3), 167.55 (OCOCH3), 152.21 (C-5′), 151.84 (C-3), 111.21 (C-4), 96.85 (C-4′), 95.83 (C-1′), 91.76 (C-1), 79.46 (C-7), 68.39 (C-2′), 64.46 (C-3′), 62.24 (C-6′), 51.22 (OCH3), 46.13 (C-8), 43.19 (C-9), 42.08 (C-6), 32.18 (C-5), 20.91 (OCOCH3), 20.65 (OCOCH3), 18.42 (C-10). 12a MS (FAB); m/z; 415 (M++1), 437 (M++Na), [α] D=-60.81 (C=0.12 in CHCl3), 1H NMR (400 MHz, CDCl3), δ 7.38 (s, 1H, H-3), 5.48 (d, 3, 1H, H-1′), 5.20 (d, 5.9, 1H, H-1), 5.18 (te, 1H, H-7), 5.14 (d, 5, 1H, H-4′), 4.10 (bs, 2H, H-6′), 4.00 (bs, 1H, H-3′), 3.95 (bs, 1H, H-2′), 3.73 (s, 3H, OCH3), 3.09 (m, 1H, H-5), 2.38 (me, 1H, H-9), 2.32 (me, 1H, H-6), 2.07 (s, 3H, COCH3), 2.05 (m, 1H, H-8), 1.76 (m, 1H, H-6), 1.10 (d, 8, 3H, H-10); 13C NMR (100 MHz, CDCl3), δ 170.78 (COOMe), 167.27 (OCOCH3), 150.42 (C-3), 150.29 (C-5′), 111.42 (C-4), 100.20 (C-4′), 96.03 (C-10) 95.87 (C-1), 70.60 (C-7), 69.78 (C-2′), 65.88 (C-3′), 62.04 (C-6′), 51.35 (OCH3), 45.91 (C-9), 39.16 (C-8), 38.98 (C-6), 30.89 (C-5), 20.29 (OCOCH3), 13.07 (C-10). 12b MS(FAB); m/z; 395 (M++ Na), [α]D-9.75 (C=0.13 in CH3OH), 1H NMR (400 MHz, CD3OD), δ 7.39 (S, 1H, H-3), 5.26 (d, 6, 1H, H-1′), 5.23 (d, 5, 1H, H-1), 5.01 (d, 3, 1H, H-4′), 4.03 (m, 1H, H-7), 3.99 (t, 5, 1H, H-3′), 3.93 (s, 2H, H-6′), 3.69 (s, 3H, OCH3), 3.64 (t, 5, 1H, H-2′), 3.60 (m, 1H, H-5), 2.23 (m, 1H, H-6), 2.01 (m, 1H, H-9), 1.84 (m, 1H, H-8), 1.57 (m, 1H, H-6), 1.10 (d, 8, 3H, H-10); 13C NMR (100 MHz, CD3OD), δ 169.40 (COOCH3), 152.28 (C-5′), 151.84 (C-3), 140.27 (C-4), 101.00 (C-4′), 97.88 (C-1′ and C-1′), 74.98 (C-7), 72.01 (C-2′), 68.04 (C-3′), 62.31 (C-6′), 51.63 (OCH3), 46.50 (C-9), 42.83 (C-6), 42.29 (C-8), 32.21 (C-5), 13.38 (C-10). [e denotes overlapping with other signals]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.